Other

2027

Abbott 2027 increased by 100.0% to $3.00B in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), 2027 shows an upward trend with a 9.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ2 2025
Last reportedQ1 2026

How to read this metric

High maturity amounts in a single year can signal potential liquidity pressure if cash flow is insufficient for repayment or refinancing.

Detailed definition

This represents the specific portion of long-term debt principal scheduled for repayment during the 2027 fiscal year. It...

Peer comparison

Companies with staggered debt maturity profiles are generally viewed as having lower refinancing risk than those with large 'bullet' maturities.

Metric ID: other_long_term_debt_maturities_repayments_of_principal__d4f4c9

Historical Data

4 periods
 Q4 '22Q4 '23Q4 '24Q4 '25
Value$2.30B$1.10B$1.50B$3.00B
QoQ Change-52.2%+36.4%+100.0%
YoY Change-52.2%+36.4%+100.0%
Range$1.10B$3.00B
Avg YoY Growth+28.1%
Median YoY Growth+36.4%
Current Streak2 quarters growth

Frequently Asked Questions

What is Abbott's 2027?
Abbott (ABT) reported 2027 of $3.00B in Q4 2025.
What is the long-term trend for Abbott's 2027?
Over 3 years (2022 to 2025), Abbott's 2027 has grown at a 9.3% compound annual growth rate (CAGR), from $2.30B to $3.00B.
What does 2027 mean?
The amount of long-term debt principal that must be repaid in 2027.